IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dick, A. D.
Right arrow Articles by Wright, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dick, A. D.
Right arrow Articles by Wright, G. J.
(Investigative Ophthalmology and Visual Science. 2001;42:170-176.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Distribution of OX2 Antigen and OX2 Receptor within Retina

Andrew D. Dick1,2, Cathryn Broderick2, John V. Forrester2 and Gavin J. Wright3

1 From the Division of Ophthalmology, University of Bristol; the 2 Department of Ophthalmology, University of Aberdeen Medical School; and the 3 Sir William Dunn School of Pathology, University of Oxford, United Kingdom.

PURPOSE. OX2 is a member of the immunoglobulin superfamily expressed on a broad range of tissues including neurons of the central and peripheral nervous systems, thymocytes, and endothelium. The recently identified OX2 receptor (OX2R) is restricted to the surfaces of myeloid lineage cells, including microglia. Functional data have implicated the OX2–OX2R interaction as a myeloid downregulatory signal. The purpose of this study was to determine the distribution and extent of expression of OX2 and its receptor within the retina, a tissue developed to restrain immune-mediated inflammatory damage.

METHODS. OX2 and OX2R monoclonal antibodies (mAbs) were used to determine OX2 and OX2R protein expression, respectively, by flow cytometry of isolated myeloid-derived cells from normal and inflamed rat retina and by immunohistochemistry of serial sections of rat retina. For comparison, distribution of OX2 was documented using species-specific monoclonal antibodies in mouse and human retina. No OX2R mAbs are available for mouse or human detection.

RESULTS. OX2 was expressed on retinal vascular endothelium and glial fibrillary acidic protein (GFAP)–negative neurons in retina and optic nerve and on a subpopulation of CD45+ perivascular and juxtavascular cells. Within normal retina, OX2R was not detected on myeloid-derived cells. During experimental autoimmune uveoretinitis (EAU), expression of both OX2 and OX2R was noted on infiltrating leukocytes.

CONCLUSIONS. Taking these results of the distribution of OX2 in normal and OX2R in inflamed retina with other functional data of OX2–OX2R interaction, it is suggested that the OX2–OX2R interaction has the potential to contribute to a novel pathway that suppresses and limits immunologic inflammatory damage within the retina.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
D. A. Copland, C. J. Calder, B. J.E. Raveney, L. B. Nicholson, J. Phillips, H. Cherwinski, M. Jenmalm, J. D. Sedgwick, and A. D. Dick
Monoclonal Antibody-Mediated CD200 Receptor Signaling Suppresses Macrophage Activation and Tissue Damage in Experimental Autoimmune Uveoretinitis
Am. J. Pathol., August 1, 2007; 171(2): 580 - 598.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Langmann
Microglia activation in retinal degeneration
J. Leukoc. Biol., June 1, 2007; 81(6): 1345 - 1351.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Voisin, A. E. Firar, V. Avondo, and M. Laburthe
Orexin-Induced Apoptosis: The Key Role of the Seven-Transmembrane Domain Orexin Type 2 Receptor
Endocrinology, October 1, 2006; 147(10): 4977 - 4984.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Taylor, K. McConnachie, C. Calder, R. Dawson, A. Dick, J. D. Sedgwick, and J. Liversidge
Enhanced Tolerance to Autoimmune Uveitis in CD200-Deficient Mice Correlates with a Pronounced Th2 Switch in Response to Antigen Challenge
J. Immunol., January 1, 2005; 174(1): 143 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. S. Gregerson, T. N. Sam, and S. W. McPherson
The Antigen-Presenting Activity of Fresh, Adult Parenchymal Microglia and Perivascular Cells from Retina
J. Immunol., June 1, 2004; 172(11): 6587 - 6597.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. D. Dick, D. Carter, M. Robertson, C. Broderick, E. Hughes, J. V. Forrester, and J. Liversidge
Control of myeloid activity during retinal inflammation
J. Leukoc. Biol., August 1, 2003; 74(2): 161 - 166.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. S. Gregerson and J. Yang
CD45-Positive Cells of the Retina and Their Responsiveness to In Vivo and In Vitro Treatment with IFN-{gamma} or Anti-CD40
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3083 - 3093.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
D A Carter and A D Dick
Lipopolysaccharide/interferon-{gamma} and not transforming growth factor {beta} inhibits retinal microglial migration from retinal explant
Br. J. Ophthalmol., April 1, 2003; 87(4): 481 - 487.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Broderick, R. M. Hoek, J. V. Forrester, J. Liversidge, J. D. Sedgwick, and A. D. Dick
Constitutive Retinal CD200 Expression Regulates Resident Microglia and Activation State of Inflammatory Cells during Experimental Autoimmune Uveoretinitis
Am. J. Pathol., November 1, 2002; 161(5): 1669 - 1677.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Yang, L. Chen, R. Zwart, and A. Kijlstra
Immune Cells in the Porcine Retina: Distribution, Characterization and Morphological Features
Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1488 - 1492.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology